J. Wojton and B. Kaur, Impact of tumor microenvironment on oncolytic viral therapy, Cytokine & Growth Factor Reviews, vol.21, issue.2-3, pp.127-161, 2010.
DOI : 10.1016/j.cytogfr.2010.02.014

F. Galivo, R. Diaz, P. Wongthida, J. Thompson, T. Kottke et al., Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma, Gene Therapy, vol.67, issue.2, pp.158-70161, 2009.
DOI : 10.1016/S0092-8674(00)80350-5

R. Prestwich, F. Errington, R. Diaz, H. Pandha, K. Harrington et al., The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon, Human Gene Therapy, vol.20, issue.10, pp.1119-32135, 2009.
DOI : 10.1089/hum.2009.135

S. Naik and S. Russell, Engineering oncolytic viruses to exploit tumor specific defects in innate immune Frontiers in Oncology | Tumor Immunity